WHO Greenlights Two Ebola Bundibugyo Virus Vaccine Candidates for Phase 2/3 Trials
WHO has greenlighted Phase 2/3 trials for two brand new vaccine candidates that specifically target the Ebola Bundibugyo virus species ravaging the Democratic Republic of Congo. Actual trials could forseeably commence “within three to four weeks” – as soon as DRC regulators issue their own approval, said WHO’s Science Director Meg Doherty, at a Wednesday […]
We haven't written up this one. Health Policy Watch has the full story — the link below goes straight to it.